Hepatitis B virus (HBV) infects more than 250 million people worldwide and may result in cirrhosis and hepatocellular carcinoma (Wands & Blum, 1991) . Currently, the most effective and approved therapy for chronic hepatitis B is parenteral application of recombinant human interferon alpha (Hoofnagle & di Bisceglie, 1997) . However, interferon treatment results in elimination of infectious virus only in an estimated 30-40 % of treated patients (Wong et al., 1993).
Understanding the factors that contribute to treatment failure in the majority of patients is pertinent. The strict species specificity of human HBV and the lack of in vitro cell culture systems for HBV infection make the study of hepadnavirus infections in animal models an attractive experimental system. Therefore, woodchuck hepatitis virus (Summers et al., 1978) , ground squirrel hepatitis virus (Marion et al., 1980) and duck hepatitis B virus (DHBV) (Mason et al., 1980) are widely used animal models for investigating the mechanisms of viral infection and evaluating antiviral strategies (Seeger et al., 1991) . The study of interferon action in these animal models has been hampered by the lack of readily available interferons from these species. Interferons from other species are ineffective, since interferons are a family of strictly species specific proteins with potent antiviral, antiproliferative and immunomodulatory activities (DeMaeyer & DeMaeyerGuignard, 1988 ; Gray & Goeddel, 1982 ; Lengyel, 1982 ; Pestka et al., 1987 ; Weissmann & Weber, 1986) . The recent cloning and biochemical characterization of duck interferon (Schultz et al., 1995) allowed the effects of interferon in the DHBV model to be studied for the first time.
Mature duck interferon is a 161 amino acid peptide with 50 % identity to chicken interferon. Sequence homology to mammalian interferons is marginal, but conservation of four cysteine residues and inducibility by virus indicate a distant relationship between duck interferon and mammalian type I interferons (Schultz et al., 1995) . Purified recombinant duck interferon from Escherichia coli has been shown to be biologically active in vitro : it activates the interferon-inducible Mx gene, prevents cell destruction by cytolytic RNA viruses, and has a strong inhibitory effect on DHBV in cultured primary duck hepatocytes (Schultz et al., 1995) . Recombinant duck interferon intended for experimental use in vivo was first tested in vitro : primary duck hepatocytes were isolated from 10-dayold DHBV infected and uninfected Peking ducks, as described Tuttleman et al., 1986) , and incubated for 5 days with 100, 1000 and 10 000 U\ml recombinant duck interferon. DNA was isolated as described (Offensperger et al., 1993) , and analysed by Southern blot Fig. 1 . Effects of duck interferon on DHBV infection in ducks. Ten pg linearized DHBV DNA was loaded in lanes A1 and B1 (arrows). (A) Southern blot : DHBV infected primary duck hepatocytes were left untreated (lane A2), or treated with 100 (A3), 1000 (A4) or 10 000 (A5) U/ml duck interferon for 5 days. Ten µg cellular DNA was separated on a 1 % agarose gel. After blotting to a nylon membrane, filters were hybridized to a 32 P-labelled full-length DHBV DNA probe. (B) Southern blot : posthatching (day 2) DHBV infected ducklings (total number 14) were treated from day 14 to 24 with daily intravenous injections of duck interferon in various concentrations, human interferon alpha at 100 U/g body weight (two animals, lanes B12 and B13) or 0n9 % NaCl (two animals, lanes B14 and B15). Four ducklings were treated with 1000 U/g body weight (lanes B2-B5), two animals with 500 U/g body weight (lanes B6 and B7) and two animals with 100 U/g body weight (lanes B8-B11). DNA was extracted from liver cell homogenates.
hybridization using a $#P-labelled full-length DHBV DNA probe (Fig. 1 A) . A dose dependent decrease of viral DNA was observed in this in vitro experiment, confirming the biological activity of duck interferon as previously published (Schultz et al., 1995) .
The in vivo effect of recombinant duck interferon was tested by parenteral treatment of DHBV infected ducklings. Two days after hatching, ducklings were infected by intravenous injection of 100 µl DHBV positive serum (" 10* virions\ml). At age 14 days, i.e. 12 days after infection, ducks were given daily intravenous injections of various doses of interferon for 10 consecutive days. At the end of the treatment period, ducks were sacrificed and DNA was extracted from liver cells as described (Offensperger et al., 1988) . Treatment of four ducks with 1000 U interferon per g body weight resulted in a reduction of viral DNA in the liver, compared to the controls treated with human interferon (two animals) or 0n9 % NaCl (two animals) (Fig. 1 B) . Interferon doses of 500 and 100 U\g resulted in intermediate reductions in DHBV DNA in liver cells (Fig. 1 B) . The effects of interferon treatment on DHBV viraemia were analysed by dot blot analysis of duck sera. During the treatment period from day 14 to 24, blood samples were taken daily from each animal. From each serum sample, 10 µl was denatured for 10 min at 68 mC in 5i SSC, 7n5% formaldehyde, 1 M NaOH and 1n5 % Sarkosyl, dot-blotted onto a nylon membrane and hybridized to a $#P-labelled fulllength DHBV DNA probe (Walter et al., 1987) . Viraemia was reduced in all animals that were treated with interferon, in many cases below the level of detection (Fig. 2) .
Having confirmed the biological efficacy of recombinant duck interferon in the DHBV infection model in vitro and in vivo, we examined whether duck interferon makes use of intracellular signal transduction pathways similar to those of its mammalian counterparts. In contrast to human HBV infection, where interferon alpha is effective in only a minority of patients, all the ducks treated in our experiments showed antiviral activity of recombinant duck interferon in vivo. Is the cloned duck interferon a typical type I interferon ? Does it activate similar, homologous signal transduction pathways to mammalian type I interferons ? Activation of different intracellular signals could explain the differences in antiviral activities in ducks and humans.
Mammalian interferons bind to specific transmembrane receptors at the surface of target cells and induce intracellular signal transduction to the nucleus through the Jak-STAT (signal transducer and activator of transcription) pathway Heim, 1996) . In humans and mice, type I interferons (interferon alpha and interferon beta) bind to a heterodimeric receptor composed of interferon alpha receptor-1 (IFNAR1) (Uze et al., 1990) and IFNAR2 (Domanski et al., 1995 ; Novick et al., 1994) . Binding of the ligand activates two intracellular protein tyrosine kinases, Tyk2 and Jak1 (Muller et al., 1993 ; Pellegrini et al., 1989) . The activated kinases then phosphorylate tyrosine residues on the receptors (Lutfalla et al., Fig. 2 . Dot blot analysis of duck sera from 18 animals. Blood was taken daily from DHBV infected ducks. Ten µl serum was applied per dot. DHBV DNA was detected by hybridization to a 32 P-labelled full-length DHBV DNA probe. (A) Eight ducklings were infected with DHBV at day 2 posthatching. From day 12 to 22 after infection, four animals were left untreated, and four were injected daily with 1000 U/g body weight of duck interferon as indicated. (B) Ten ducklings were infected at day 2 post-hatching. From day 12 to 22 after infection, two animals were injected daily with 0n9 % NaCl, two were treated with human interferon alpha (100 U/g body weight), four were injected daily with 100 U, and two with 500 U duck interferon per gram body weight, as indicated.
1995 ; Yan et al., 1996 a) , which are bound consecutively by the Src homology 2 (SH2) domains of STAT1, STAT2 and STAT3 (Heim et al., 1995 ; Schindler et al., 1992 b ; Silvennoinen et al., 1993) . The STATs are then phosphorylated on a conserved tyrosine residue located immediately C-terminal of the SH2 domain (Shuai et al., 1993) and form heterodimers or homodimers (Fu et al., 1992 ; Shuai et al., 1994 ; Zhong et al., 1994 b) . STAT3 and STAT1 form homodimers, designated SIF-A and SIF-C, respectively, and a STAT1-STAT3 heterodimer, SIF-B, that can be detected by electrophoretic mobility shift assay (EMSA) using the oligonucleotide probe m67 derived from the promoter of the c-fos gene (Wagner et al., 1990) . STAT1 can also dimerize with STAT2, and this STAT1-STAT2 heterodimer associates with a third DNA binding protein, ISGF3γ-p48, to form interferon stimulated response factor 3 (ISGF3) (Fu et al., 1992) . ISGF3 binds to a different response element and can be detected by EMSA with the oligonucleotide probe ISRE derived from the promoter of interferon stimulated gene 15 (Reich et al., 1987) . Binding of these STAT factors to their cognate sequences in the promoter regions of target genes results in enhanced transcription of these genes. The Jak-STAT pathway is conserved over wide evolutionary distances as demonstrated by the finding of STATs and STAT response elements in gene promoters in Drosophila and Dictyostelium (Hou et al., 1996 ; Kawata et al., 1997 ; Yan et al., 1996 b) .
We tested interferon induced signal transduction events in primary duck hepatocytes from DHBV infected and uninfected ducks. After 48 h in culture, subconfluent cell monolayers were stimulated with recombinant duck interferon, and nuclear extracts were prepared as described (Levy et al., 1989) . Extracts were analysed for the presence of interferon activated STATlike proteins by EMSA with the STAT specific response elements ISRE (5h GAAAGGGAAACCGAACTGAAGC 3h) and mSIE (5h CATTTCCCGTAATCAT 3h) from mammalian gene promoters (Levy et al., 1989) . Interestingly, an ISGF3-like gel shift could be detected in interferon stimulated duck hepatocytes (Fig. 3 A) . The shift is detected after 15 min interferon treatment. Peak intensity of the shift is observed after 45 min treatment and the shift remains detectable for at least 2 h treatment (data not shown). The intensity of the gel shift signal is dose dependent with maximal intensity already achieved at 500 U\ml in many cases (Fig. 3 A) . The kinetics displayed by this duck interferon induced gel shift activity are very similar to the ISGF3 shift in human fibroblasts (Levy et al., 1989) . Analysed with the second STAT gel shift probe, the mSIE oligonucleotide, the familiar SIF-A, SIF-B and SIF-C pattern observed in murine P13 cells after interferon alpha treatment was also detected in ducks (Fig. 3 B) . Apparently, duck interferon activates mainly STAT1 in duck hepatocytes, resulting in strong SIF-C-like gel shift complexes and weak SIF-B-like and SIF-A-like complexes. The same time-course (data not shown) and dose-response (Fig. 3 B) characteristics as for ISGF3 were observed.
Are duck STATs activated by Jak kinases ? Detection of duck Jaks by antibodies to human Jak1, human Tyk2 (both from Transduction Laboratories) and mouse Jak2 (Upstate) was not possible owing to lack of cross-reactivity.
Next, gel shift experiments were done to test whether some of these STAT-like duck proteins could be recognized by antibodies raised against mammalian STAT proteins. We analysed the following antisera : anti-STAT1 C-terminus ; anti-STAT2 C-terminus (Fu et al., 1992) ; anti-STAT3 C-terminus (Zhong et al., 1994 a) ; anti-STAT4 C-terminus (Zhong et al., 1994 a) ; anti-STAT5 Cterminus (Ghilardi et al., 1996) ; anti-STAT6 C-terminus (Ghilardi et al., 1996) ; pre-immune serum ; anti-STAT1 Nterminus ; polyclonal anti-STAT1 SH2-domain, raised in rabbits against the fusion protein between Fig. 3 . Analysis of interferon induced intracellular signal transduction. (A, B) Primary duck hepatocytes from an uninfected duck (lanes 1-4, 9-11, 15-17) and a congenitally DHBV infected duck (lanes 5-8, 12-14, 18-20) were cultured for 48 h, then treated with 5000 (lanes 2, 6, 9, 12, 15, 18), 500 (lanes 3, 7, 10, 13, 16, 19) or 50 (lanes 4, 8, 11, 14, 17, 20 ) U/ml duck interferon. Controls were left untreated (lanes 1 and 5). Treatment was for 15 min (lanes 1-8), 45 min (lanes 9-14) or 2 h (lanes 15-20). Nuclear extracts were analysed by EMSA with the ISRE probe (A) or the mSIE probe (B). An ISGF3-like shift is induced (arrow, A) as well as SIF-A-, SIF-B-and SIF-C-like complexes (arrows, B). (C) Primary duck hepatocytes were left untreated (lane 1) or treated for 30 min with 5000 U/ml duck interferon (lanes 2-12). Nuclear extracts were incubated in a total volume of 12n5 µl with the ISRE probe only (lanes 1 and 2) or together with 1 µl undiluted STAT specific antisera : anti-STAT1 C-terminus (3), anti-STAT2 C-terminus (4), anti-STAT3 Cterminus (5), anti-STAT4 C-terminus (6), anti-STAT5 C-terminus (7), antiamino acids 573-671 of human STAT1 and maltose binding protein (MBP) ; and polyclonal rabbit anti-STAT3 SH2-domain, raised against a fusion protein between amino acids 580-677 of murine STAT3 and MBP. Tested in mammalian cell extracts, the latter two antibodies specifically recognize STAT1 and STAT3, respectively (data not shown). All the sera that were used against STATs are strictly specific for the STAT they were raised against, and all cross-react with STATs from other mammals (human, monkey, mouse and sheep). The ISGF3-like shift can be completely shifted away by antisera raised in rabbit against the SH2 domain of human STAT1 (Fig. 3 C, lane 11) , and partially shifted away by human STAT2 C-terminus specific antisera (Fig. 3 C, lane 4) . Addition of any of the rabbit antisera to the gel shift samples resulted in the appearance of an additional, slower migrating shift (Fig. 3 C, asterisk) , but only the STAT2-C-terminus and the STAT1-SH2 domain specific antisera clearly weakened the duck interferon inducible ISGF3-like shift (Fig. 3 C) . Based on the binding to ISRE and the ability to shift away the duck interferon stimulated gel shift with antisera against STAT1 and STAT2, it is concluded that duck interferon induces an ISGF3-like activity in primary duck hepatocytes. Duck and mammalian interferons, therefore, appear to signal through closely related signal transduction pathways.
What is the molecular mechanism for the apparent resistance of HBV towards interferon induced antiviral cellular defence ? In an interesting report, Foster et al. (1991) showed that the stable introduction of an expression construct encoding the polymerase of HBV into the human sarcoma cell line 2fTGH resulted in marked inhibition of interferon induced signalling through ISGF3. We therefore tested whether DHBV infection alters duck interferon induced signal transduction through the duck homologue of ISGF3. Primary duck hepatocytes from DHBV infected and uninfected animals were stimulated with recombinant duck interferon at different concentrations for 15 min, 45 min and 2 h. As shown in Fig.  3 (A, B) , no inhibition of ISGF3 activation in DHBV infected animals could be detected in our in vivo model. That the infected ducks used in the experiments were productively infected was shown by the Western blot demonstrating DHBV preS antigen in serum from infected, but not from uninfected animals (data not shown).
In conclusion, the recently cloned duck interferon probably signals through duck homologues of the mammalian STAT proteins, and has antiviral activity in vivo. Contrary to the situation in 2fTGH cells overexpressing the polymerase gene of HBV, DHBV infection does not inhibit interferon induced signalling in hepatocytes. For the further study of interferon STAT6 C-terminus (8), pre-immune serum (9), anti-STAT1 N-terminus (10), anti-STAT1 SH2-domain (11) and anti-STAT3 SH2-domain (12). An unspecific band shift appears with all antisera (asterisk). The position of the ISGF3-like complex is lower and indicated by an arrow. ISGF3-like shifts are shifted away partially by anti-STAT2 C-terminus (lane 4), and completely by anti-STAT1 SH2-domain serum.
actions and viral defence strategies, DHBV infection in ducks is a promising animal model.
